Sleep apnea and risk of retinal vein occlusion: A nationwide population-based study of Taiwanese

American Journal of Ophthalmology

Volumn 154, Issue 1, 2012, Pages 200-205.e1

  Chou, Kun Ta ^a,b   Huang, Chin Chou ^a,b   Tsai, Der Chong ^b   Chen, Yuh Min ^a,b   Perng, Diahn Warng ^a,b   Shiao, Guang Ming ^a,b   Lee, Yu Chin ^a,b   Leu, Hsin Bang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; BRAIN ISCHEMIA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLAUCOMA; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TAIWAN;

EID: 84862773877     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.01.011     Document Type: Article

References (34)

1. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157(1):144-148. (Pubitemid 28071275)
2. Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national Sleep Foundation Sleep in America 2005 Poll. Chest 2006;130(3):780-786. (Pubitemid 44423609)
3. Selim B, Won C, Yaggi HK. Cardiovascular consequences of sleep apnea. Clin Chest Med 2010;31(2):203-220.
4. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010;8(9):1886-1894.
5. Glacet-Bernard A, Leroux les Jardins G, Lasry S, et al. Obstructive sleep apnea among patients with retinal vein occlusion. Arch Ophthalmol 2010;128(12):1533-1538.
6. Bureau of National Health Insurance. 2002. 2001 National Health Insurance Annual Statistical Report. Taipei, Taiwan.
7. National Health Research Institutes. National Health Insurance Research Database. Available at: http://w3.nhri.org.tw/nhird//date-01.html. Updated 2007. Accessed December 30, 2011.
8. National Health Research Institutes. National Health Insurance Research Database. Available at: http://w3.nhri.org.tw/nhird/en/Research.html.Updated 2010. Accessed December 30, 2011.
9. Ho JD, Liou SW, Lin HC. Retinal vein occlusion and the risk of stroke development: a five-year follow-up study. Am J Ophthalmol 2009;147(2):283-290.
10. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126(5):692-699. (Pubitemid 351679566)
11. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93(6):1021-1026. (Pubitemid 40823503)
12. Leroux les Jardins G, Glacet-Bernard A, Lasry S, Housset B, Coscas G, Soubrane G. Retinal vein occlusion and obstructive sleep apnea syndrome. J Fr Ophtalmol 2009;32(6):420-424.
13. Ambrosetti M, Lucioni A, Ageno W, Conti S, Neri M. Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost 2004;2(10):1858-1860. (Pubitemid 40192731)
14. Arnulf I, Merino-Andreu M, Perrier A, Birolleau S, Similowski T, Derenne JP. Obstructive sleep apnea and venous thromboembolism. JAMA 2002;287(20):2655-2656. (Pubitemid 34533542)
15. von Kanel R, Natarajan L, Ancoli-Israel S, Mills PJ, Loredo JS, Dimsdale JE. Day/night rhythm of hemostatic factors in obstructive sleep apnea. Sleep 2010;33(3):371-377.
16. Guardiola JJ, Matheson PJ, Clavijo LC, Wilson MA, Fletcher EC. Hypercoagulability in patients with obstructive sleep apnea. Sleep Med 2001;2(6):517-523. (Pubitemid 34026951)
17. Mehra R, Xu F, Babineau DC, et al. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010;182(6):826-833.
18. von Kanel R, Loredo JS, Ancoli-Israel S, Mills PJ, Natarajan L, Dimsdale JE. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 2007;131(3):733-739. (Pubitemid 46446864)
19. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009;51(5):351-362.
20. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009;32(4):447-470.
21. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009;33(6):1467-1484.
22. Rius J, Guma M, Schachtrup C, et al. NF-kappa B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008;453(7196):807-811. (Pubitemid 351793778)
23. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-kappa B in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006;343(2):591-596.
24. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010;38(2 Suppl):S26-S34.
25. Olson LJ, Olson EJ, Somers VK. Obstructive sleep apnea and platelet activation: another potential link between sleep-disordered breathing and cardiovascular disease. Chest 2004;126(2):339-341. (Pubitemid 39093413)
26. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/ American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118(10):1080-1111.
27. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373(9657):82-93.
28. Lim LL, Cheung N, Wang JJ, et al. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol 2008;92(10):1316-1319.
29. Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 2005;112(4):540-547. (Pubitemid 41108850)
30. David R, Zangwill L, Badarna M, Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 1988;197(2):69-74.
31. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114(10):1243-1247. (Pubitemid 26338856)
32. The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993;116(3):286-296.
33. Prisco D, Marcucci R, Bertini L, Gori AM. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002;13(3):163-169. (Pubitemid 34518506)
34. Yau JW, Lee P, Wong TY, Best J, Jenkins A. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 2008;38(12):904-910.